BRPI0819828A8 - Processo de síntese de oligômeros de morfolino - Google Patents

Processo de síntese de oligômeros de morfolino

Info

Publication number
BRPI0819828A8
BRPI0819828A8 BRPI0819828A BRPI0819828A BRPI0819828A8 BR PI0819828 A8 BRPI0819828 A8 BR PI0819828A8 BR PI0819828 A BRPI0819828 A BR PI0819828A BR PI0819828 A BRPI0819828 A BR PI0819828A BR PI0819828 A8 BRPI0819828 A8 BR PI0819828A8
Authority
BR
Brazil
Prior art keywords
group
morpholino
synthesis
lower alkyl
morpholin
Prior art date
Application number
BRPI0819828A
Other languages
English (en)
Inventor
Mary Josephine Fox Christina
Dale Reeves Matthew
Li Yongfu
D Weller Dwight
Original Assignee
Avi Biopharma Inc
Sarepta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avi Biopharma Inc, Sarepta Therapeutics Inc filed Critical Avi Biopharma Inc
Publication of BRPI0819828A2 publication Critical patent/BRPI0819828A2/pt
Publication of BRPI0819828A8 publication Critical patent/BRPI0819828A8/pt
Publication of BRPI0819828B1 publication Critical patent/BRPI0819828B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCESSO DE SÍNTESE DE OLIGÔMEROS DE MORFOLINO. São fornecidos compostos de morfilino que têm a estrutura (I): em que R¹ é selecionado do grupo que consiste em alquila inferior , di ( alquila inferior) amino e fenila;R² é selecionada do grupo que consiste em alquila inferior , arilmetila monocíclico (arlóxi) metila monocíclico ; R³ é selecionado do grupo que consiste em triarilmetila e hidrogênio ; e Y é selecionado do grupo que consiste em: um grupo hidroxila ou amino protegido ou desprotegido ; um grupo clorofosforamidato ; e uma ligação de fosforodiamidato ao nitrogênio do anel de um composto de morfolino adicional ou de um aligômero de morfolino. Tais compostos incluem monômeros de morfolino guanina (MoG) duplamente protegido. Também é descrito seu uso na síntese de oligômeros de morfolino e outros procedimentos aperfeiçoados para a síntese de oligômeros de morfolino, referente á desproteção do nitrogênio do anel de morfolino protegido em cada etapa de acoplamento do monômero.
BRPI0819828-4A 2007-11-15 2008-11-14 Compostos de morfolino e processos para sintetizar um oligômero de morfolino BRPI0819828B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US98820007P 2007-11-15 2007-11-15
US98819207P 2007-11-15 2007-11-15
US60/988.192 2007-11-15
US60/988.200 2007-11-15
PCT/US2008/012804 WO2009064471A1 (en) 2007-11-15 2008-11-14 Method of synthesis of morpholino oligomers

Publications (3)

Publication Number Publication Date
BRPI0819828A2 BRPI0819828A2 (pt) 2015-05-26
BRPI0819828A8 true BRPI0819828A8 (pt) 2022-12-27
BRPI0819828B1 BRPI0819828B1 (pt) 2025-09-09

Family

ID=

Also Published As

Publication number Publication date
CA2884340A1 (en) 2009-05-22
JP2011503184A (ja) 2011-01-27
RU2010123958A (ru) 2011-12-20
AU2008321409B2 (en) 2014-08-14
CN101861318A (zh) 2010-10-13
BR122019021332A8 (pt) 2022-12-06
CA2884340C (en) 2017-07-25
JP5512533B2 (ja) 2014-06-04
JP2014159432A (ja) 2014-09-04
MX2010004955A (es) 2010-06-30
KR101617472B1 (ko) 2016-05-02
CA2704261C (en) 2015-05-26
CA2704261A1 (en) 2009-05-22
BRPI0819828A2 (pt) 2015-05-26
AU2008321409A1 (en) 2009-05-22
HRP20140646T1 (hr) 2014-09-26
HK1144424A1 (en) 2011-02-18
BR122019021332A2 (pt) 2015-05-26
JP2016196494A (ja) 2016-11-24
RU2606627C2 (ru) 2017-01-10
KR20100090681A (ko) 2010-08-16
JP6178744B2 (ja) 2017-08-09
EP2207779B1 (en) 2014-04-09
EP2207779A1 (en) 2010-07-21
WO2009064471A1 (en) 2009-05-22
DK2207779T3 (da) 2014-07-14
ES2479393T3 (es) 2014-07-24
IL205776A0 (en) 2010-11-30

Similar Documents

Publication Publication Date Title
BR122019021332A8 (pt) Processo de síntese de oligômeros de morfolino
Dai et al. Towards shell biorefinery: advances in chemical‐catalytic conversion of chitin biomass to organonitrogen chemicals
Correia‐da‐Silva et al. Emerging sulfated flavonoids and other polyphenols as drugs: Nature as an inspiration
ES2528285T3 (es) Molécula de ácido nucleico monocatenario que tiene esqueleto alicíclico que contiene nitrógeno
Balmond et al. A 3, 4‐trans‐Fused Cyclic Protecting Group Facilitates α‐Selective Catalytic Synthesis of 2‐Deoxyglycosides
Kumpan et al. Structure-based design, synthesis and evaluation in vitro of arylnaphthyridinones, arylpyridopyrimidinones and their tetrahydro derivatives as inhibitors of the tankyrases
BR0014225A (pt) Derivados de pirazol
BRPI0512643A (pt) sistema catalisador para a polimerização de etileno, componente catalisador de titánio sólido, e métodos para produzir um suporte de catalisador e para produzir um polietileno
BRPI0108841B8 (pt) derivado de pirimidina, processo para prepapar o mesmo, e composição farmacêutica
BRPI0519759A2 (pt) composiÇÕes farmacÊuticas
JP2009524696A5 (pt)
BR0112456A (pt) Compostos de piperidina para uso como inibidores de ccr-3
BRPI0009763B8 (pt) sequência de ácido nucléico codificando uma preniltransferase, construção compreendendo a mesma, bem como métodos para alteração do teor de tocoferol, produção de um composto de tocoferol,e aumento do fluxo biossintético em uma célula
CL2007001495A1 (es) Compuestos derivados de 4-imidazol-pirimidin-2-amina, inhibidores de la cinasa cdk2;proceso para preparar los compuestos;composicion farmaceutica que comprende a un compuesto;y uso de los compuestos en la preparacion de medicamentos para la proliferacion anticelular,tal como cancer,psoriasis,artritis reumatoide,entre otras.
BR0111667A (pt) Novos compostos
BRPI0615307A2 (pt) agonistas de adrenorreceptor alfa2c
EA200802129A1 (ru) 6-о-замещенные бензоксазолы и бензотиазолы и способы подавления передачи сигналов от csf-1r
BG104938A (bg) Заместени индолинони, тяхното получаване и тяхното приложение като лекарствени средства
BRPI0517737A (pt) inibidores de quinase
MX2011012631A (es) Inhibidores de actividad de cinasa tipo pirimidina.
BRPI0407841A (pt) inibidores heterocìclicos de quinase
ECSP034865A (es) Resolución óptica de (1-benzilo-4-metilopiperidina-3-il)-metilamina y su uso para la preparación de derivados de pirrolo 2,3-pirimidina como inhibidores de proteina quinasas
TW200633979A (en) Method
BR0313727A (pt) Derivados de isoquinolina como inibidores de metaloproteinase da matriz
BR0208900A (pt) Indolinas substituìdas na posição 6 e seu uso como inibidores de cinase

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B25D Requested change of name of applicant approved

Owner name: SAREPTA THERAPEUTICS, INC. (US)

B25G Requested change of headquarter approved

Owner name: SAREPTA THERAPEUTICS, INC. (US)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/11/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.